Zcash News Today: ZEC Whale's $5M Collateral Gamble: Can the Short Survive a Privacy Coin Rally?

Generated by AI AgentCoin WorldReviewed byAInvest News Editorial Team
Wednesday, Nov 19, 2025 3:47 am ET1min read
Speaker 1
Speaker 2
AI Podcast:Your News, Now Playing
Aime RobotAime Summary

- A ZEC short whale on Hyperliquid faces $13.77M losses as Zcash surges past $700, with 10x leverage and a $1,084 liquidation price.

- The whale added $5M

collateral to sustain the position, expanding the short size to $43.2M amid ZEC's 1,500% October-November rally.

- ZEC's rise to $11.2B market cap, driven by institutional interest and privacy coin adoption, highlights risks of leveraged bets in volatile crypto markets.

- The position reflects broader on-chain dynamics, with the whale also holding profitable ETH shorts but facing imminent ZEC liquidation if prices remain above $686.

The largest

short position on Hyperliquid, a prominent crypto derivatives exchange, as of November 19, according to on-chain analytics firm Lookonchain. The position, opened at $360 per (ZEC) in late October, has faced mounting pressure as the asset's price surged past $700, . Funding fees alone have already eroded over $536,000 for the whale maintaining the short, .

The short, held by address 0xd47...51A91, employs 10x leverage and faces a liquidation price of $1,084. Despite the losses, the whale has

, including a $5 million deposit on November 16 to bolster the position. This strategy of "averaging down" costs has seen the short size expand from an initial $29.26 million in early November to $43.2 million as of November 19, during the same period. The address has held the position since October 10, initially entering at a much lower price of $184, and has systematically increased exposure during ZEC's volatile rally .

ZEC's price trajectory has been a key driver of the short's struggles. The asset, which

in late November after a 1,500% surge since October, has become the 12th-largest cryptocurrency by market capitalization, surpassing $11.2 billion. The rally has drawn attention from institutional players, , who disclosed that ZEC is the second-largest liquid asset in his family office, Maelstrom. Meanwhile, biotech firm Leap Therapeutics , a ZEC treasury company, with backing from the Winklevoss twins, further fueling market enthusiasm.

The short's challenges reflect broader on-chain dynamics. Hyperliquid's data shows the whale also maintains a 15x ETH short worth $26 million,

, and multiple leveraged short positions in and . However, the ZEC short remains the most precarious, with its liquidation price now just 34% above the current $686 level. on ZEC's ability to retreat from recent highs, a scenario that appears increasingly unlikely given renewed interest in privacy protocols and ongoing debates about Bitcoin's OP_CAT opcode reactivation.

The short's persistence highlights the risks of high-leverage bets in rapidly moving markets. While the whale has managed to avoid liquidation through aggressive collateral additions, further gains in ZEC could force a partial or full unwind. This situation mirrors broader market trends, where leveraged positions are being tested as privacy-focused assets like ZEC gain traction amid regulatory scrutiny and technological innovation.